■ Demo— not a validated GxP system — synthetic data

Affinis

Compound registry

KIN-07 · EGFR mutant-selective — structures, computed properties and batches

Register a compound…
Series
Status
Registered compounds, with their computed properties and mutant-EGFR potency
StructureCompoundSeriesR-groupsFormulaMWcLogPTPSA (Ų)BatchespIC50 mutStatus
NHNNFOAFN-003350BR1 F · R6 H · R7 OEtC16H14FN3O283.33.9147.00—designed
NHNNFOOAFN-003351BR1 F · R6 H · R7 OCH2CH2OMeC17H16FN3O2313.33.5456.30—designed
NHNNFFAFN-003352BR1 F · R6 H · R7 FC14H9F2N3257.23.6537.816.21tested
NHNNFONOAFN-003353BR1 F · R6 H · R7 O(CH2)2-morpholinoC20H21FN4O2368.43.2259.50—designed
NHNNFClAFN-003354BR1 F · R6 H · R7 ClC14H9ClFN3273.74.1737.80—designed
NHNNFOHAFN-003355BR1 F · R6 H · R7 OHC14H10FN3O255.33.2258.00—designed
NHNNFOAFN-003356BR1 F · R6 OMe · R7 HC15H12FN3O269.33.5247.00—designed
NHNNFOOAFN-003357BR1 F · R6 OMe · R7 OMeC16H14FN3O2299.33.5356.30—designed
NHNNFOOAFN-003358BR1 F · R6 OMe · R7 OEtC17H16FN3O2313.33.9256.30—designed
NHNNFOOOAFN-003359BR1 F · R6 OMe · R7 OCH2CH2OMeC18H18FN3O3343.43.5565.50—designed
NHNNFOFAFN-003360BR1 F · R6 OMe · R7 FC15H11F2N3O287.33.6647.00—designed
NHNNFOONOAFN-003361BR1 F · R6 OMe · R7 O(CH2)2-morpholinoC21H23FN4O3398.43.2368.70—designed
NHNNFOClAFN-003362BR1 F · R6 OMe · R7 ClC15H11ClFN3O303.74.1747.00—designed
NHNNFOOHAFN-003363BR1 F · R6 OMe · R7 OHC15H12FN3O2285.33.2367.30—designed
NHNNFOAFN-003364BR1 F · R6 OEt · R7 HC16H14FN3O283.33.9147.00—designed
NHNNFOOAFN-003365BR1 F · R6 OEt · R7 OMeC17H16FN3O2313.33.9256.30—designed
NHNNFOOAFN-003366BR1 F · R6 OEt · R7 OEtC18H18FN3O2327.44.3156.30—designed
NHNNFOOOAFN-003367BR1 F · R6 OEt · R7 OCH2CH2OMeC19H20FN3O3357.43.9465.50—designed
NHNNFOFAFN-003368BR1 F · R6 OEt · R7 FC16H13F2N3O301.34.0547.00—designed
NHNNFOONOAFN-003369BR1 F · R6 OEt · R7 O(CH2)2-morpholinoC22H25FN4O3412.53.6268.70—designed
NHNNFOClAFN-003370BR1 F · R6 OEt · R7 ClC16H13ClFN3O317.84.5647.00—designed
NHNNFOOHAFN-003371BR1 F · R6 OEt · R7 OHC16H14FN3O2299.33.6267.30—designed
NHNNFOOAFN-003372BR1 F · R6 OCH2CH2OMe · R7 HC17H16FN3O2313.33.5456.30—designed
NHNNFOOOAFN-003373BR1 F · R6 OCH2CH2OMe · R7 OMeC18H18FN3O3343.43.5565.50—designed
NHNNFOOOAFN-003374BR1 F · R6 OCH2CH2OMe · R7 OEtC19H20FN3O3357.43.9465.50—designed
NHNNFOOOOAFN-003375BR1 F · R6 OCH2CH2OMe · R7 OCH2CH2OMeC20H22FN3O4387.43.5674.70—designed
NHNNFOOFAFN-003376BR1 F · R6 OCH2CH2OMe · R7 FC17H15F2N3O2331.33.6856.30—designed
NHNNFOOONOAFN-003377BR1 F · R6 OCH2CH2OMe · R7 O(CH2)2-morpholinoC23H27FN4O4442.53.2578.00—designed
NHNNFOOClAFN-003378BR1 F · R6 OCH2CH2OMe · R7 ClC17H15ClFN3O2347.84.1956.30—designed
NHNNFOOOHAFN-003379BR1 F · R6 OCH2CH2OMe · R7 OHC17H16FN3O3329.33.2476.50—designed
NHNNFONOAFN-003380BR1 F · R6 O(CH2)3-morpholino · R7 HC21H23FN4O2382.43.6159.50—designed
NHNNFONOOAFN-003381BR1 F · R6 O(CH2)3-morpholino · R7 OMeC22H25FN4O3412.53.6268.70—designed
NHNNFONOOAFN-003382BR1 F · R6 O(CH2)3-morpholino · R7 OEtC23H27FN4O3426.54.0168.716.69tested
NHNNFONOOOAFN-003383BR1 F · R6 O(CH2)3-morpholino · R7 OCH2CH2OMeC24H29FN4O4456.53.6478.00—designed
NHNNFONOFAFN-003384BR1 F · R6 O(CH2)3-morpholino · R7 FC21H22F2N4O2400.43.7559.50—designed
NHNNFONOONOAFN-003385BR1 F · R6 O(CH2)3-morpholino · R7 O(CH2)2-morpholinoC27H34FN5O4511.63.3281.20—designed
NHNNFONOClAFN-003386BR1 F · R6 O(CH2)3-morpholino · R7 ClC21H22ClFN4O2416.94.2759.50—designed
NHNNFONOOHAFN-003387BR1 F · R6 O(CH2)3-morpholino · R7 OHC21H23FN4O3398.43.3279.71—tested
NHNNFNHOAFN-003388BR1 F · R6 acrylamido · R7 HC17H13FN4O308.33.6466.90—designed
NHNNFNHOOAFN-003389BR1 F · R6 acrylamido · R7 OMeC18H15FN4O2338.33.6576.10—designed
NHNNFNHOOAFN-003390BR1 F · R6 acrylamido · R7 OEtC19H17FN4O2352.44.0476.10—designed
NHNNFNHOOOAFN-003391BR1 F · R6 acrylamido · R7 OCH2CH2OMeC20H19FN4O3382.43.6685.40—designed
NHNNFNHOFAFN-003392BR1 F · R6 acrylamido · R7 FC17H12F2N4O326.33.7866.90—designed
NHNNFNHOONOAFN-003393BR1 F · R6 acrylamido · R7 O(CH2)2-morpholinoC23H24FN5O3437.53.3588.61—tested
NHNNFNHOClAFN-003394BR1 F · R6 acrylamido · R7 ClC17H12ClFN4O342.84.2966.90—designed
NHNNFNHOOHAFN-003395BR1 F · R6 acrylamido · R7 OHC17H13FN4O2324.33.3487.10—designed
NHNNClAFN-003396BR1 Cl · R6 H · R7 HC14H10ClN3255.74.0337.80—designed
NHNNClOAFN-003397BR1 Cl · R6 H · R7 OMeC15H12ClN3O285.74.0447.00—designed
NHNNClOAFN-003398BR1 Cl · R6 H · R7 OEtC16H14ClN3O299.84.4347.00—designed
NHNNClOOAFN-003399BR1 Cl · R6 H · R7 OCH2CH2OMeC17H16ClN3O2329.84.0556.30—designed

Properties calculated with RDKit offline, not at runtimeSubstructure: our own screen fingerprint, then VF2 matching — no RDKit at runtimepIC50 mut = mean of approved fits on ASY-EGFR-TM-03